Andrea Franson Selected Research

Fever (Fevers)

1/2024

Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Franson Research Topics

Disease

6	Neoplasms (Cancer) 11/2023 - 12/2020
6	Glioma (Gliomas) 11/2023 - 01/2020
1	Anorexia 01/2024
1	Fever (Fevers) 01/2024
1	Neuroblastoma 01/2024
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2021

Drug/Important Bio-Agent (IBA)

3	Circulating Tumor DNAIBA 11/2023 - 12/2020
3	TIC10 compoundIBA 11/2023 - 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2024
1	Celecoxib (Celebrex)FDA Link 01/2024
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2024
1	Transaminases (Aminotransferases)IBA 01/2024
1	Nucleosomes (Nucleosome)IBA 11/2023
1	Oncogene Proteins (Oncogene Protein)IBA 11/2023
1	Proteins (Proteins, Gene)FDA Link 11/2023
1	Histone Deacetylase InhibitorsIBA 01/2021
1	PanobinostatIBA 01/2021
1	dipinacoline glutamateIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	1-methyltryptophanIBA 01/2020
1	Histones (Histone)IBA 01/2020

Therapy/Procedure

6	Therapeutics 01/2024 - 01/2020
1	Combined Modality Therapy 12/2022
1	Radiotherapy 12/2022
1	Immunotherapy 01/2022